Linked Life Data

16919856

Source:http://linkedlifedata.com/resource/pubmed/id/16919856

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2007-3-19
pubmed:abstractText
To evaluate hepatitis B virus (HBV) risk group vaccination in Amsterdam, which started in 1998, we examined 342 reported acute HBV-cases and sequenced 85 DNA isolates. The reported number of cases declined from 214 in 1992-1997 to 128 in 1998-2003, due to a decline in injecting drug users (IDU) and their heterosexual partners. Phylogenetic analyses showed that after 1998, the IDU cluster nearly disappeared, probably due to a decline in injecting. Acute HBV remained stable among men having sex with men; given their increased sexual risk behavior, vaccination has probably prevented an increase in their acute infections. Currently, 48-72% of the people who should be included in the program are still susceptible to HBV.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0264-410X
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2698-705
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.
pubmed:affiliation
GGD, Public Health Service, Department of Infectious Diseases, Amsterdam, The Netherlands. rvhoudt@ggd.amsterdam.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't